Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Apr;105(4):783–786. doi: 10.1111/j.1476-5381.1992.tb09057.x

Enteral absorption of octreotide.

G Fricker 1, J Drewe 1, J Vonderscher 1, T Kissel 1, C Beglinger 1
PMCID: PMC1908725  PMID: 1504712

Abstract

1. The somatostatin octapeptide-analogue, octreotide, is absorbed as intact peptide from the gastrointestinal (GI) tract. 2. In situ absorption experiments in rats confirmed our recent intubation studies in human volunteers demonstrating that the peptide has preferential absorption sites in the small intestine. Absorption of octreotide was higher in the jejunum than in the duodenum or the ileum. 3. Experiments with bile-duct cannulated rats demonstrated that the absorption of octreotide decreased in the presence of bile, reflecting a negative influence of biliary components on the absorption of the peptide. 4. Uptake experiments using rat jejunal brush border membranes were performed to analyse the absorption mechanisms. The transport of octreotide into jejunal brush border membranes was significantly higher than the uptake into membrane vesicles isolated from rat ileum. When initial uptake (0-15s) rates into the membrane vesicles were calculated as a function of the peptide concentration, a saturable component could be observed, indicative of transport mechanisms different from simple diffusion.

Full text

PDF
783

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amoss M., Rivier J., Guillemin R. Release of gonadotropins by oral administration of synthetic LRF or a tripeptide fragment of LRF. J Clin Endocrinol Metab. 1972 Jul;35(1):175–177. doi: 10.1210/jcem-35-1-175. [DOI] [PubMed] [Google Scholar]
  2. Battershill P. E., Clissold S. P. Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion. Drugs. 1989 Nov;38(5):658–702. doi: 10.2165/00003495-198938050-00002. [DOI] [PubMed] [Google Scholar]
  3. Bauer W., Briner U., Doepfner W., Haller R., Huguenin R., Marbach P., Petcher T. J., Pless SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci. 1982 Sep 13;31(11):1133–1140. doi: 10.1016/0024-3205(82)90087-x. [DOI] [PubMed] [Google Scholar]
  4. Beschiaschvili G., Seelig J. Peptide binding to lipid membranes. Spectroscopic studies on the insertion of a cyclic somatostatin analog into phospholipid bilayers. Biochim Biophys Acta. 1991 Jan 9;1061(1):78–84. doi: 10.1016/0005-2736(91)90270-i. [DOI] [PubMed] [Google Scholar]
  5. Fricker G., Bruns C., Munzer J., Briner U., Albert R., Kissel T., Vonderscher J. Intestinal absorption of the octapeptide SMS 201-995 visualized by fluorescence derivatization. Gastroenterology. 1991 Jun;100(6):1544–1552. doi: 10.1016/0016-5085(91)90651-z. [DOI] [PubMed] [Google Scholar]
  6. Fuessl H. S., Domin J., Bloom S. R. Oral absorption of the somatostatin analogue SMS 201-995: theoretical and practical implications. Clin Sci (Lond) 1987 Feb;72(2):255–257. doi: 10.1042/cs0720255. [DOI] [PubMed] [Google Scholar]
  7. Ganapathy V., Burckhardt G., Leibach F. H. Characteristics of glycylsarcosine transport in rabbit intestinal brush-border membrane vesicles. J Biol Chem. 1984 Jul 25;259(14):8954–8959. [PubMed] [Google Scholar]
  8. Gardner M. L. Intestinal assimilation of intact peptides and proteins from the diet--a neglected field? Biol Rev Camb Philos Soc. 1984 Aug;59(3):289–331. doi: 10.1111/j.1469-185x.1984.tb00708.x. [DOI] [PubMed] [Google Scholar]
  9. Hopfer U., Nelson K., Perrotto J., Isselbacher K. J. Glucose transport in isolated brush border membrane from rat small intestine. J Biol Chem. 1973 Jan 10;248(1):25–32. [PubMed] [Google Scholar]
  10. Humphrey M. J., Ringrose P. S. Peptides and related drugs: a review of their absorption, metabolism, and excretion. Drug Metab Rev. 1986;17(3-4):283–310. doi: 10.3109/03602538608998293. [DOI] [PubMed] [Google Scholar]
  11. Köhler E., Duberow-Drewe M., Drewe J., Ribes G., Loubatiéres-Mariani M. M., Mazer N., Gyr K., Beglinger C. Absorption of an aqueous solution of a new synthetic somatostatin analogue administered to man by gavage. Eur J Clin Pharmacol. 1987;33(2):167–171. doi: 10.1007/BF00544562. [DOI] [PubMed] [Google Scholar]
  12. Lamberts S. W., Uitterlinden P., Verschoor L., van Dongen K. J., del Pozo E. Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995. N Engl J Med. 1985 Dec 19;313(25):1576–1580. doi: 10.1056/NEJM198512193132504. [DOI] [PubMed] [Google Scholar]
  13. Lundin S., Vilhardt H. Absorption of 1-deamino-8-D-arginine vasopressin from different regions of the gastrointestinal tract in rabbits. Acta Endocrinol (Copenh) 1986 Jul;112(3):457–460. doi: 10.1530/acta.0.1120457. [DOI] [PubMed] [Google Scholar]
  14. Murer H., Hopfer U. Demonstration of electrogenic Na+-dependent D-glucose transport in intestinal brush border membranes. Proc Natl Acad Sci U S A. 1974 Feb;71(2):484–488. doi: 10.1073/pnas.71.2.484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pless J., Bauer W., Briner U., Doepfner W., Marbach P., Maurer R., Petcher T. J., Reubi J. C., Vonderscher J. Chemistry and pharmacology of SMS 201-995, a long-acting octapeptide analogue of somatostatin. Scand J Gastroenterol Suppl. 1986;119:54–64. doi: 10.3109/00365528609087432. [DOI] [PubMed] [Google Scholar]
  16. Satoh O., Kudo Y., Shikata H., Yamada K., Kawasaki T. Characterization of amino-acid transport systems in guinea-pig intestinal brush-border membrane. Biochim Biophys Acta. 1989 Oct 16;985(2):120–126. doi: 10.1016/0005-2736(89)90355-6. [DOI] [PubMed] [Google Scholar]
  17. Takaori K., Burton J., Donowitz M. The transport of an intact oligopeptide across adult mammalian jejunum. Biochem Biophys Res Commun. 1986 Jun 13;137(2):682–687. doi: 10.1016/0006-291x(86)91132-0. [DOI] [PubMed] [Google Scholar]
  18. Tsuji A., Terasaki T., Tamai I., Hirooka H. H+ gradient-dependent and carrier-mediated transport of cefixime, a new cephalosporin antibiotic, across brush-border membrane vesicles from rat small intestine. J Pharmacol Exp Ther. 1987 May;241(2):594–601. [PubMed] [Google Scholar]
  19. Williams G., Ball J. A., Burrin J. M., Joplin G. F., Bloom S. R. Effective and lasting growth-hormone suppression in active acromegaly with oral administration of somatostatin analogue SMS 201-995. Lancet. 1986 Oct 4;2(8510):774–778. doi: 10.1016/s0140-6736(86)90300-4. [DOI] [PubMed] [Google Scholar]
  20. Wilson D., Barry J. A., Ramaswamy K. Characteristics of tripeptide transport in human jejunal brush-border membrane vesicles. Biochim Biophys Acta. 1989 Nov 17;986(1):123–129. doi: 10.1016/0005-2736(89)90280-0. [DOI] [PubMed] [Google Scholar]
  21. del Pozo E. Clinical applications of somatostatin. Horm Res. 1988;29(2-3):89–91. doi: 10.1159/000180976. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES